Agenus Inc.
-
Ticker
AGEN
-
Industry
Biotechnology More
-
Sector
Healthcare More
- 201-500 Employees
- Based in Lexington, Massachusetts
Agenus Inc., a biotechnology company, develops and commercializes immunotherapies for cancer and infectious diseases. It markets Oncophage vaccine for the treatment of adjuvant renal cell carcinoma (kidney cancer).
REPORT RATINGS
4.8 / 5.0 (179)
Agenus Inc. reports have an aggregate usefulness score of 4.8 based on 179 reviews.
Agenus Inc.
Most Recent Annual Report
MOST RECENT
2023 Annual Report and Form 10K
Older/Archived Annual Reports